Growth Metrics

Angiodynamics (ANGO) Divestments (2023 - 2024)

Angiodynamics posted quarterly Divestments of $34.5 million for Q1 2024, down 65.5% on a QoQ basis from $100.0 million in Q3 2023.

Angiodynamics (ANGO) has 2 years of Divestments data on file, last reported at $34.5 million in Q1 2024.

  • For the quarter ending Q1 2024, Divestments changed N/A year-over-year to $34.5 million; the trailing twelve-month figure through Nov 2024 stood at $34.5 million (down 65.5% YoY), and the FY2024 full-year result was $134.5 million, changed N/A from the prior year.
  • Divestments for Q1 2024 stood at $34.5 million, down from $100.0 million in the prior quarter.
  • Across five years, Divestments topped out at $100.0 million in Q3 2023 and bottomed at $34.5 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Angiodynamics 497.07 Mn 459.26 Mn 41.48 Mn -

Historic Data

Download Data 🔒
DateValue
Feb 29, 2024 34.50 Mn
Aug 31, 2023 100.00 Mn